Search Within

Philip Wayne Kantoff

Formats
  1. Journal Article (118)
  2. Meeting Abstract (71)
  3. Review (4)
  4. Correspondence (2)
  5. Editorial (2)
  6. Research Letter (1)
Groups
  1. Department of Medicine (198)
  2. Genitourinary Oncology Service (198)
  3. Solid Tumor Oncology Division (198)
  4. Sloan Kettering Institute Postdocs (71)
  5. GSK Faculty (26)
  6. Human Oncology and Pathogenesis Program (23)

More Groups

People
  1. Konrad Stopsack (44)
  2. Goutam Chakraborty (29)
  3. Ying Mazzu (29)
  4. Subhiksha Nandakumar (27)
  5. Michael Morris (26)
  6. Yuki Yoshikawa (23)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (19)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (17)
  3. Cancer Research (16)
  4. Cancer (9)
  5. Cancer Epidemiology Biomarkers and Prevention (8)
  6. European Urology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (62)
  2. American Association for Cancer Research (46)
  3. Nature Publishing Group (16)
  4. Oxford University Press (11)
  5. Wiley Blackwell (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP)
    Meeting Abstract

    Sweeney, C.; Xie, W.; Regan, M. M.; Nakabayashi, M.; Buyse, M. E.; Clarke, N. W.; Collette, L.; Dignam, J. J.; Fizazi, K.; Habibian, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
    Meeting Abstract

    Sanford, N. N.; Chen, M. H.; Loffredo, M. J.; Renshaw, A. A.; Kantoff, P. W.; D'Amico, A. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genome-wide association study (GWAS) of response to androgen deprivation therapy (ADT) and survival in metastatic prostate cancer (PCa)
    Meeting Abstract

    Pomerantz, M.; Wang, X. V.; Kantoff, P. W.; Xie, W.; Kohli, M.; Lee, G. S. M.; Wang, E.; Chen, Y. H.; Hahn, N. M.; Jarrard, D. F.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • An investigator-initiated phase I study of crizotinib in combination with enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) before or after progression on docetaxel
    Meeting Abstract

    Harshman, L. C.; Gray, K. P.; Polacek, L.; Taplin, M. E.; Choudhury, A. D.; Pomerantz, M. M.; Bellmunt, J.; Yu, C.; Sun, Z.; Srinivas, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP)
    Meeting Abstract

    Xie, W.; Sweeney, C.; Regan, M.; Nakabayashi, M.; Buyse, M.; Clarke, N.; Collette, L.; Dignam, J.; Fizazi, K.; Habibian, M.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Everolimus / pazopanib (E/P) benefits genomically selected patients (pts) with metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Bellmunt, J.; Mullane, S. A.; Jacobus, S.; Polacek, L.; Takeda, D. Y.; Harshman, L.; Choueiri, T.; Wagle, N.; Van Allen, E. M.; Kantoff, P.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
    Journal Article

    McNeel, D. G.; Bander, N. H.; Beer, T. M.; Drake, C. G.; Fong, L.; Harrelson, S.; Kantoff, P. W.; Madan, R. A.; Oh, W. K.; Peace, D. J.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • To put that into context
    Journal Article

    Solit, D. B.; Kantoff, P. W.
    Oncology (Norwalk) (2016)

    Fulltext@MSK | Save
  • Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
    Meeting Abstract

    Sanford, N. N.; Chen, M. H.; Loffredo, M.; Renshaw, A.; Kantoff, P. W.; D'Amico, A. V.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Physical and emotional health information needs and preferences of long-term prostate cancer survivors
    Journal Article

    Zhou, E. S.; Bober, S. L.; Nekhlyudov, L.; Hu, J. C.; Kantoff, P. W.; Recklitis, C. J.
    Patient Education and Counseling (2016)

    Fulltext@MSK | Save